analyst
NASDAQ · IDYA
IDEAYA Biosciences, Inc.
Healthcare · Biotechnology
$40.11
Down-$0.01 (-0.02%)
Updated Aug 31, 2026, 8:46 PM
SID Score
6.3/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 2.94B
- P/E ratio
- -8.97
- Dividend yield
- 0.00%
- 52-week range
- $23.23 – $42.68
- Volume
- 714.07K
- Avg. volume
- 1.13M
Price performance
IDYA price history
1M range · 20 trading sessions · Daily adjusted prices
IDYA closed at $40.11 after 20 trading sessions, up 13.31% for the selected period.
- Last close
- $40.11
- Period change
- +13.31%
- Period low
- $35.40
- Period high
- $42.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 28, 2026 | $41.14 | $41.635 | $40.04 | $40.11 | 714.07K |
| Aug 27, 2026 | $41.63 | $42.095 | $40.965 | $41.77 | 534.41K |
| Aug 26, 2026 | $42.26 | $42.325 | $41.09 | $41.58 | 724.9K |
| Aug 25, 2026 | $40.88 | $42.68 | $40.06 | $42.48 | 1.02M |
| Aug 24, 2026 | $39.73 | $40.46 | $39.12 | $40.04 | 786.77K |
| Aug 21, 2026 | $39.34 | $40.56 | $39.31 | $39.67 | 860.57K |
| Aug 20, 2026 | $38.24 | $39.28 | $37.8894 | $39.11 | 1.63M |
| Aug 19, 2026 | $39.01 | $39.2995 | $37.84 | $38.87 | 931.92K |
| Aug 18, 2026 | $36.41 | $37.975 | $36.3883 | $37.93 | 629.49K |
| Aug 17, 2026 | $36.04 | $36.82 | $35.80 | $36.54 | 427.84K |
| Aug 14, 2026 | $36.68 | $36.68 | $35.66 | $36.30 | 435.26K |
| Aug 13, 2026 | $36.915 | $37.63 | $36.615 | $36.68 | 466.19K |
| Aug 12, 2026 | $36.75 | $37.20 | $36.46 | $36.96 | 508.83K |
| Aug 11, 2026 | $36.48 | $37.3525 | $36.025 | $36.84 | 488.6K |
| Aug 10, 2026 | $36.98 | $37.48 | $36.175 | $36.74 | 717.24K |
| Aug 7, 2026 | $36.50 | $37.03 | $36.27 | $37.02 | 602.34K |
| Aug 6, 2026 | $36.07 | $36.9149 | $36.00 | $36.24 | 497.72K |
| Aug 5, 2026 | $36.27 | $36.97 | $35.7812 | $36.04 | 1M |
| Aug 4, 2026 | $36.295 | $36.72 | $35.21 | $36.11 | 1.25M |
| Aug 3, 2026 | $35.13 | $35.9899 | $34.56 | $35.40 | 395.8K |
Latest IDYA news
The latest Smart Investors Daily articles mentioning IDYA.
Stock researchResearch & News · SEC Filings
Loading stock research…